TCTMD: Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK
BTK inhibitors are a type of targeted therapy for mantle cell lymphoma that works by blocking a specific enzyme, BTK, which is crucial for the cancer cells’ survival and spread. This interference ...
How to get reliable current time in Flutter when device time is changed (offline mode)? [closed] I’m working on a Flutter application where I need to track accurate time (e.g., for attendance, session tracking, or time-based validations). Question: What is the best way to handle accurate time ...
The American Journal of Managed Care: Review Emphasizes Potential Infection Risks With BTK Inhibitors
BTK inhibitors increase infection risk in B-cell lymphoma patients, necessitating proactive monitoring and prophylactic strategies. BTK inhibition affects immune functions, impairing pathogen ...
The American Journal of Managed Care: Infection Risk With BTK Inhibitors Low, New CLL Study Finds
Only about 1% of patients with chronic lymphocytic leukemia (CLL) developed an invasive fungal infection while on a Bruton’s tyrosine kinase (BTK) inhibitor, investigators found. A new analysis of ...
Seeking Alpha: Nurix Therapeutics: Speculative Bet On BTK Degraders And Targeted Protein Modulation
Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like NX-5948. The company’s DELigase platform allows for targeted protein modulation ...
LAS VEGAS, NV—At 2 years, a drug-eluting resorbable scaffold continues to show sustained patency and safety compared with conventional angioplasty alone in patients with below-the-knee (BTK) chronic ...
MedPage Today: Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL